Drugs / KB15A.16.2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07222020 | Jan → Sep 2026 overdue | — | ZabBio Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KB15A.16.2 | “KB15A is a polyvinyl-alcohol (PVA) based intravaginal contraceptive film Drug Product manufactured by KBio, Inc. containing the KB15A.16.2 Drug Substance.” NCT07222020 ↗ |
| Modality | Monoclonal antibody | “KB15A.16.2 is an IgG1 monoclonal antibody” NCT07222020 ↗ |
| Route | Other | “intravaginal film” NCT07222020 ↗ |